Table 1.
Characteristics | Total | TARBP1 | P value | |
---|---|---|---|---|
|
||||
Positive | Negative | |||
Gender | 0.731 | |||
Male | 81 | 50 | 31 | |
Female | 9 | 5 | 4 | |
Age (years) | 0.189 | |||
≥60 | 22 | 11 | 11 | |
<60 | 67 | 44 | 23 | |
Hepatitis | 0.641 | |||
HBV/HCV | 4 | 2 | 2 | |
Negative | 86 | 53 | 33 | |
Live cirrhosis | 0.708 | |||
Presence | 33 | 21 | 12 | |
Absence | 57 | 34 | 23 | |
Tumor size (cm) | 0.318 | |||
≥5 | 53 | 35 | 18 | |
<5 | 36 | 20 | 16 | |
AJCC tumor stage | 0.004 | |||
I | 9 | 3 | 6 | |
II | 48 | 25 | 23 | |
III | 33 | 27 | 6 | |
Clinical stage | 0.005 | |||
1 | 11 | 3 | 8 | |
2 | 29 | 15 | 14 | |
3 | 42 | 32 | 10 |
HBV, hepatitis B virus; HCV, hepatitis C virus; AJCC, American Joint Committee on Cancer.